UNSW-linked dementia research has been given a major boost with six academics receiving prestigious Dementia Research Development Fellowships worth up to $605,000 each.
UNSW researchers have uncovered a new biomarker for schizophrenia that provides further insight into the development of the debilitating disease and may ultimately improve diagnosis and treatment.
Still Alice is a poignant window on the world of the millions of people living with Alzheimer’s disease and a powerful motivation in the quest for a cure, write Muireann Irish and Rebekah Ahmed.
Brain research in Australia has received a significant boost with the opening of a world-class $54 million facility – part of the Neuroscience Research Precinct.
Research has found the brains of people with schizophrenia may be under attack by the immune system, with 40 per cent of patients shown to have increased inflammation.
UNSW scientists will receive $18 million for research into early onset dementia and mood disorders, Federal Health Minister Tanya Plibersek announced during a visit to the University.
